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Infectious agents are a leading cause of pregnancy
complications and contribute to serious illness, death, and
disability in infants. Substantial prevention opportunities exist.
Role of Infectious Agents in Adverse Consequences
of Pregnancy
A variety of studies have assessed the role of sexually
transmitted infections (e.g., Neisseria gonorrhoeae, Chlamy-
dia trachomatis, Trichomonas vaginalis) and other genital
tract infections (e.g., those caused by group B streptococcus
[GBS], bacterial vaginosis [BV]) in preterm deliveries.
Although numerous studies have shown that the presence of
each of these agents can increase the risk of preterm
delivery, nearly every antimicrobial treatment trial failed
to show a beneficial effect in reducing preterm deliveries or
numbers of newborns of low birth weight. A consistently
strong association between BV and preterm delivery has
been identified, yet only two randomized controlled trials,
out of approximately 15 clinical trials, found that
antimicrobial treatment during pregnancy had a positive
impact. The typical intervention trial targeted a single
infectious agent, even though the agents used have broad
effects on multiple organisms and interactions exist among
genital tract flora. Future research approaches may benefit
from abandoning the paradigm of the randomized controlled
trial that attempts to vary a single parameter and instead
adopting holistic approaches to address multiple pathogens in
concert.
Maternal Immunization
Vaccination of pregnant women has a long history, and
several vaccines are now routinely recommended during
pregnancy. An essential factor to consider is that the placenta
is an extremely complex immunologic organ, with highly
selective placental transport of immunoglobulin G that is
receptor-mediated and active. Vaccinations are given in the
last trimester to avoid effects on organogenesis. Excellent
safety profiles were observed for several vaccines given
during a large perinatal project conducted by the National
Institutes of Health from 1957 to 1966. Nevertheless, legal
liability for manufacturers remains a barrier. The high
background rate of congenital anomalies and fetal loss is
compounded by the challenges of distinguishing temporal
relationships from causal ones. Despite these factors,
active  research is proceeding on maternal immunization
against GBS, Streptococcus pneumoniae, and respiratory
syncytial virus (RSV) using polysaccharide and protein
conjugate vaccines as well as RSV-subunit vaccines (PFP-2).
Control of Infectious Diseases Through Breast-Feeding
Breast-feeding reduces illness and death from infectious
diseases in all socioeconomic settings. Maternal exposure and
antibodies generally negate any impact of passage of
infectious agents. The one rare, but important, exception is
passage of retroviruses, including HIV, in cells. Breast milk
contains cellular (e.g., T and B lymphocytes, neutrophils,
macrophages) and noncellular (e.g., immunoglobulins,
hormones, enzymes) components, both of which contribute
to preventing infection. Exclusive breast-feeding is
associated with the greatest reduction in illness and death
from infectious agents when compared to results from partial
breast-feeding. Models have estimated tremendous economic
and health benefits of increasing the proportion of women who
breast-feed; increases will only occur where breast-feeding
skills are supported by both the health and social systems.
Studies need to differentiate between exclusive breast-
feeding, partial breast-feeding, and exclusive formula
feeding to carefully determine risk-benefits for women and
infants in particular settings.
Prevention Success Stories
Several features differentiate perinatal infections from
other infectious disease syndromes: 1) the time during which
disease transmission can occur is limited; 2) eradication of the
pathogen from the mother is not essential in preventing
transmission; 3) researchers have avoided testing in pregnant
women and newborns because they are vulnerable
populations; and 4) pregnancy provides opportunities to
integrate public health response. During the 1990s, efforts to
prevent perinatal transmission of HIV and GBS in the United
States were highly successful, with an 86% reduction in
perinatally acquired AIDS and a 70% reduction in early-onset
GBS disease. Racial disparity was reduced significantly in
both circumstances. Keys to success included advocacy,
surveillance, support by professional organizations, and the
integration of perinatal prevention programs.
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